Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice

Virology

Volumn 245, Issue 2, 1998, Pages 216-228

  Charles, Peter C ^a   Guida, Jack D ^a   Brosnan, Celia F ^a   Horwitz, Marshall S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; ELECTRON MICROSCOPY; FEMALE; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HUMAN ADENOVIRUS TYPE 1; MURINE ADENOVIRUS 1; RNA VIRUSES;

EID: 0032486489     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9180     Document Type: Article

References (41)

1. Bergelson J. M., Cunningham J. A., Droguet G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. Isolation of a common receptor for Coxsackie B virus and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
2. Blailock Z. R., Rabin E. R., Melnick J. L. Adenovirus endocarditis in mice. Science. 157:1967;69-70.
3. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
4. Bosma G. C., Custer R. P., Bosma M. J. A severe combined immunodeficiency mutation in the mouse. Nature (London). 301:1983;527-530.
5. Boyle J. F., Weismiller D. G., Holmes K. V. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J. Virol. 61:1987;185-189.
6. Coutelier J. P., Van Broeck J., Wolf S. F. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1995;1955-1958.
7. Dveksler J. S., Pensiero M. N., Cardellichio C. B., Williams R. K., Jiang G. S., Holmes K. V., Dieffenbach C. W. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:1991;6881-6891.
8. Ehresmann D. W., Hogan R. N. Acceleration of scrapie disease in mice by an adenovirus. Intervirology. 25:1986;103-110.
9. Freistadt M. S., Stoltz D. A., Eberle K. E. Role of poliovirus receptors in the spread of the infection. Ann. N. Y. Acad. Sci. 753:1995;37-47.
10. Godfraind C., Langreth S. G., Cardellichio C. B., Knobler R., Coutelier J-P., Dubois-Dalq M., Holmes K. V. Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus. Lab. Invest. 73:1995;615-627.
11. Guida J. D., Brosnan C. F., Fejer G., Pirofski L., Horwitz M. S. Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J. Virol. 69:1995;7674-7681.
12. Hartley J. W., Rowe W. P. A new mouse virus apparently related to the adenovirus group. Virology. 11:1960;645-647.
13. Heck F. C., Sheldon J., W. G., Gleiser C. A. Pathogenesis of experimentally produced mouse adenovirus infection in mice. Am. J. Vet. Res. 842:1972;841-846.
14. +. J. Immunol. 150:1993;3602-3614.
15. Horwitz M. S. Adenovirus and their replication. Fields' Virology. 1990a;Raven Press, New York. p. 1679-1721.
16. Horwitz M. S. Adenoviral diseases. Fields B., Knipe D. M., Chanock R., Hirsch M. S., Melnick J. L., Monath T. P., Roizman B. Fields' Virology. 1990b;1723-1740 Raven Press, New York.
17. Horwitz M. S. Adenoviruses. Fields B. N., Knipe D. M., Howley P. M. Fields' Virology. 1996;2149-2171 Raven Press, New York.
18. Huang Y. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2:1996;1240-1243.
19. Ishibashi M., Yasue H. Adenoviruses of animals. Ginsberg H. S. The Adenoviruses. 1984;497-562 Plenum, New York.
20. Kring S. C., King C. S., Spindler K. R. Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred swiss mice. J. Virol. 69:1995;8084-8088.
21. Larsen S. H., Nathans D. Mouse adenovirus: Growth of plaque-purified FL virus in cell lines and characterization of viral DNA. Virology. 82:1977;182-195.
22. Lussier G., Smith A. L., Guénette D., Descôteaux J. P. Serological relationship between mouse adenovirus strains FL and K87. Lab. Anim. Sci. 37:1987;55-57.
23. Mentel R., Dopping G., Wegner U., Seidel W., Liebermann H., Dohner L. Adenovirus-receptor interaction with human lymphocytes. J. Med. Virol. 51:1997;252-257.
24. Mombaerts P., Iacomini J., Johnson R. S., Herrup K., Tonegawa S., Papaioannou V. E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 68:1992;869-877.
25. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J. L., Arenzana-Seisdedos F., Schwartz O., Heard J. M., Clark-Lewis I., Legler D. F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
26. Park B. H., Lavi E., Gaulton G. N. Intracerebral hemorrhages and infarction induced by a murine leukemia virus is influenced by host determinants within endothelial cells. Virology. 203:1994a;393-396.
27. Park B. H., Lavi E., Blank K. J., Gaulton G. N. Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J. Virol. 67:1993;6015-6024.
28. Park B. H., Lavi E., Stieber A., Gaulton G. N. Pathogenesis of cerebral infarction and hemorrhage induced by a murine leukemia virus. Lab. Invest. 70:1994b;78-85.
29. Park B. H., Matuschke B., Lavi E., Gaulton G. N. A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease. J. Virol. 68:1994c;7516-7524.
30. Pirofski L., Horwitz M. S., Scharff M. D., Factor S. Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye's syndrome. Proc. Natl. Acad. Sci. USA. 88:1991;4358-4362.
31. Raj N. B., Cheung S. C., Rosztoczy I., Pitha P. M. Mouse genotype affects inducible expression of cytokine genes. J. Immunol. 148:1992;1934-1940.
32. Shinkai Y. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:1992;855-867.
33. Smith A. L., Barthold S. W. Factors influencing susceptibility of laboratory rodents to infection with mouse adenovirus strains K 87 and FL. Arch. Virol. 95:1987;143-148.
34. Smith A. L., Winograd D. F., Burrage T. G. Comparative biological characterization of mouse adenovirus strains FL and K 87 and seroprevalence in laboratory rodents. Arch. Virol. 91:1986;233-246.
35. Van der Veen J., Mes A. Serological classification of two mouse adenoviruses. Arch. Gesamte Virusforsch. 45:1974;386-387.
36. Wickham T. J., Carrion M. E., Kovesdi I. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2:1995;750-756.
37. Wickham T. J., Filardo E. J., Cheresh D. A., Nemerow G. R. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:1994;257-264.
38. Wigand R. Age and susceptibility of swiss mice for mouse adenovirus, strain FL. Arch. Virol. 64:1980;349-357.
39. Williams R. K., Jiang G. S., Holmes K. V. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA. 88:1991;5533-5536.
40. Winters A. L., Baggett D. W., Benjamin W. R., Brown H. K., Klein T. W. Resistance to adenovirus infection after administration ofBordetella pertussis. Infect. Immun. 47:1985a;587-591.
41. Winters A. L., Baggett D. W., Lee J. D., Sloan G. L., Lemmon R. D., Stinson R. S. Immunomodulation by Bordetella pertussis: Antiviral effects. Dev. Biol. Stand. 61:1985b;233-240.